Stem Cell Spinal Cord Injury Treatment | ANOVA IRM

Stem Cell-based Treatments for Spinal Cord Injury (SCI)


The spinal cord is a long, fragile, tube-like nervous structure that connects the brain with peripheral nerves. Damage to the spinal cord, by trauma or other means, consequently results in severe motor- and sensory deficits that usually lead to the inability to move and feel. Accidents are the most common cause of Spinal Cord Injury (SCI), with catastrophic consequences for the life of the patient and their relatives. While conservative therapies aim to stabilize the patient, functional recovery in most cases is minimal.

Both preclinical and clinical studies have shown improved recovery of SCI patients when the therapy was combined with a suitable stem cell therapy. With ANOVA’s Stem Cell Secretome we provide access to the most advanced clinically available combination of stem cell-based therapies for the treatment of SCI.

Hope for patients with SCI - Therapy based on German Stem Cell technology

Nerve crossection SEM

Figure: An electron microscopy image of a cross-section of a spinal nerve, illustrating the complexity on a tiny scale. This is why nerve repair needs to happen on the cellular level with stem cells, as it can not be repaired in any other way. Image from UCSD tumblr

Spinal trauma can disrupt ascending and descending axonal pathways that lead to inflammation, demyelination and loss of neural cells (neurons). Depending on the site of injury, functional disorders induced by cellular damage usually result in the inability to move, sensory loss and/or lack of autonomous nervous system control.

Fully regenerative therapies for spinal trauma do not exist yet. However, very promising results have been obtained with stem cell transplantation in patients with spinal trauma. The use of Mesenchymal Stem Cells (MSCs) in Spinal Cord Injury has been extensively reviewed. Experiments with MSCs have shown that their abilities to stimulate repair processes in spinal cord injury are due to the paracrine secretion of the stem cells. After 21 days of observations, even though the MSCs had not been incorporated into the regenerated host tissue, there was a significant improvement in functional recovery, from as early as one week after the treatment with MSCs. The progress in this area has recently been reviewed in the scientific paper from Lamichhane and colleagues. With the ANOVA Stem Cell Secretome, which we offer at our German Clinic, we make a significant first step towards bringing these novel results to clinical use, and to the patients that are in need. We not only treat patients from Europe, but from all around the world.

There is no treatment (experimental or established) for which your treating physician can promise or even guarantee a therapeutic success. In the case of stem cell therapy, which is an experimental treatment, doctors are obliged to analyse the benefits and risks for each individual case and ensure that the benefits of the therapy outweigh the risks. When this is the case, your doctor can suggest treatment with stem cells.

Give your body a fighting chance to recover –
Get access to the latest generation of regenerative medicine

slider 5

With the latest generation of Stem Cell treatments, the Stem Cell Secretome, ANOVA, our German stem cell clinic, offers a unique and potent product that synergizes well with your physical rehabilitation recovery. Get yourself informed of your possibilities to get treated with our stem cell-based products. Contact our medical team at ANOVA to find out which stem cell therapy for spinal cord injury is an ideal treatment option for you.

References and Literature - Stem Cell-based Therapies and Spinal Cord Injuries (Click for more)

[1] A. Hejcl, J. Sedy, M. Kapcalova, D.A. Toro, T. Amemori, P. Lesny, K. Likavcanova-Masinova, E. Krumbholcova, M. Pradny, J. Michalek, M. Burian, M. Hajek, P. Jendelova, E. Sykova, HPMA-RGD hydrogels seeded with mesenchymal stem cells improve functional outcome in chronic spinal cord injury, Stem Cells Dev. 19 (2010) 1535e1546.
[2] Anthony, Diana F., and Paul G. Shiels. "Exploiting paracrine mechanisms of tissue regeneration to repair damaged organs." Transplantation research 2.1 (2013): 10.
[3] Wright KT, Masri WE, Osman A, Chowdhury J, Johnson WEB: Concise review: bone marrow for the tre atment of spinal cord injury: mechanisms and clinical implications. Stem Cells 2011, 29: 169 – 178
[4] Quertainmont R, Cantinieaux D, Bot man O, Eid S, Schoenen J, Franzen R: Mesenchymalstemcellgraftimproves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions. PLoS One 2012, 7: e39500.
[5] Lamichhane, Tek N., et al. "Emerging roles for extracellular vesicles in tissue engineering and regenerative medicine." Tissue Engineering Part B: Reviews 21.1 (2014): 45-54.
[6] Thuret, Sandrine, Lawrence DF Moon, and Fred H. Gage. "Therapeutic interventions after spinal cord injury." Nature Reviews Neuroscience 7.8 (2006): 628-643.
[7] Thuret, Sandrine, Lawrence DF Moon, and Fred H. Gage. "Therapeutic interventions after spinal cord injury." Nature Reviews Neuroscience 7.8 (2006): 628-643.
[8] Lindvall O, Kokaia Z: Stem cells for the treatment of neurological disorders. Nature 2006, 441(7097):1094-1096.
[9] Yoon SH, Shim YS, Park YH, Chung JK, Nam JH, Kim MO, Park HC, Park SR, Min BH, Kim EY, et al: Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells 2007, 25(8):2066-2073.
[10] Karamouzian S, Nematollahi-Mahani SN, Nakhaee N et al (2012) Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients. Clin Neurol Neurosurg 114(7):935–939
[11] Saito F, Nakatani T, Iwase M et al (2008) Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: the first clinical trial case report. J Trauma 64(1):53–59
[12] Saito F, Nakatani T, Iwase M et al (2012) Administration of cul¬tured autologous bone marrow stromal cells into cerebrospinal fluid in spinal injury patients: a pilot study. Restor Neurol Neu¬rosci 30(2):127–136

Patient Services at ANOVA Institute for Regenerative Medicine

Located in the center of Germany, quick access by car or train from anywhere in Europe

Simple access worldwide, less than 20 minutes from Frankfurt Airport

Individualized therapy with state-of-the-art stem cell products

Individually planned diagnostic work-up which include world-class MRI and CT scans

German high quality standard on safety and quality assurance

Personal service with friendly, dedicated Patient Care Managers

Scientific collaborations with academic institutions to assure you the latest regenerative medical programs